Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy, Safety, and PK of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

NCT07774403 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07774403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07774403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy, Safety, and PK of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Recruiting
Start date
June 24, 2026
Completion date
June 6, 2028
Enrollment
84 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis with pseudomonas aeruginosa colonization